have discovered that the opioid growth factor (OGF, [Met 5 ]-enkephalin) and its receptor, OGFr, a clinically important system with potent antitumor properties, has controlled entry from the cytoplasm to the nucleus. The nucleocytoplasmic passage of OGF -OGFr is critical to cell proliferation and suggests that there are hierarchical levels of nuclear import. This discovery, reported on page 1093 of this issue of Experimental Biology and Medicine, provides new insights into the understanding of the pathobiology of diseases related to this native biological system, and contributes to the development of new agents that will enhance treatment effectiveness.
Sciences. Drs Zagon and McLaughlin discovered the cell proliferative properties of endogenous opioids, identified OGF as the specific opioid peptide involved, and cloned and sequenced OGFr. Along with Dr Cheng, they have documented that OGF enters cells by clathrin-mediated endocytosis, showed that the OGF -OGFr complex undergoes nucleocytoplasmic trafficking, which is dependent on nuclear localization signals, and collaborated on demonstrating the remarkable properties of these native peptides in a variety of clinical studies. OGF has proven successful in Phase I and Phase II clinical trials for pancreatic cancer, and safety and efficacy studies for squamous cell carcinoma of the head and neck, and hepatocellular carcinoma are in progress. Co-author Dr McLaughlin states that 'Given the extraordinary multifaceted and subtle biological control of the cell cycle by the OGF -OGFr axis, it may be envisioned that either a loss or a gain in nucleocytoplasmic transport could contribute to the onset and progression of disease. Localization of these proteins in the wrong cellular compartments could result in pathological states.' Dr Zagon adds that 'The clinical implications of the study speak to whether changes in factors related to the nucleocytoplasmic pathway of the OGF -OGFr axis, part of the body's own machinery governing physiological processes, can be mobilized in the treatment of human disorders. Enhancement of these elements could prove extremely effective in reducing abnormal responses associated with cell proliferation as in inflammation, autoimmune diseases and cancer.' Dr Steve Goodman, Editor-in-Chief of Experimental Biology and Medicine stated 'Ian Zagon and his colleagues are responsible for describing the myriad of functions of the OGF and its receptor, OGFr, in health and disease. In this very interesting article, they have demonstrated the molecular mechanisms underlying nuclear import of OGF -OGFr. Specifically, they have demonstrated a role for karyopherin b and Ran in this process. The nuclear transport of OGF -OGFr is critical for the regulation of cell proliferation. 
